Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amplicon vectors as outstanding tools to study and modify cognitive functions.

Diana Jerusalinsky1, Alberto L Epstein

  • 1Inst. Cell Biol. & Neurosci., Prof. E. De Robertis, School Med., UBA, 2155 Paraguay Street-2nd Floor, 1121 Buenos Aires, Argentine.

Current Gene Therapy
|June 22, 2006
PubMed
Summary

Herpes simplex virus type 1 (HSV-1)-based amplicon vectors efficiently deliver genes to the brain for behavioral studies. Manipulating a few neurons can significantly alter animal behavior, suggesting a unifying hypothesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-replicative herpes simplex virus genomic and amplicon vectors for gene therapy - an update.

Gene therapy·2024
Same author

Safety of non-replicative and oncolytic replication-selective HSV vectors.

Trends in molecular medicine·2024
Same author

Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).

Cell·2023
Same author

AAV-mediated neuronal expression of an scFv antibody selective for Aβ oligomers protects synapses and rescues memory in Alzheimer models.

Molecular therapy : the journal of the American Society of Gene Therapy·2022
Same author

HSV-1's contribution as a vector for gene therapy.

Nature biotechnology·2022
Same author

Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters.

International journal of molecular sciences·2022

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Behavioral Genetics

Background:

  • Herpes simplex virus type 1 (HSV-1) based amplicon vectors are efficient tools for gene delivery.
  • These vectors are naturally neurotropic and non-toxic, making them suitable for in vivo studies.

Purpose of the Study:

  • To review recent data on HSV-1 amplicon vectors for in vivo gene delivery to rodent brains.
  • To explore their application in studying and modifying behavior, including cognitive functions and stress-related behaviors.

Main Methods:

  • Utilizing HSV-1-based amplicon vectors for targeted gene delivery in rodent models.
  • Analyzing behavioral changes following genetic manipulation in specific brain regions.

Main Results:

Related Experiment Videos

  • Demonstrated efficient and non-toxic gene delivery to rodent brains.
  • Showcased significant behavioral modifications (learning, memory, addiction, anxiety, stress) through targeted neuronal manipulation.

Conclusions:

  • HSV-1 amplicon vectors are highly effective for in vivo neuroscience research.
  • Targeted manipulation of limited neuronal populations can induce substantial behavioral changes, supporting a unifying hypothesis in behavioral neuroscience.